Table 2.
Parameter | Value |
---|---|
Age, years | 48 ± 12 |
Gender male/female, n (%) | 13 (57%) / 10 (43%) |
Height, cm | 179 ± 9 |
Weight, kg | 87 ± 18 |
BMI, kg/m2 | 27 ± 4 |
BSA, m2 | 2.0 ± 0.2 |
NYHA class I / II / III / IV, n (%) | 11 (48%) / 5 (22%) / 3 (13%) / 0 (0%) |
Indication for S-ICD implantation, n (%) | |
Suspected non-ischemic cardiomyopathy with LVEF ≤35% | 5 (22%) |
Suspected ischemic cardiomyopathy with LVEF ≤35% | 1 (4%) |
Ventricular arrhythmia of unknown origin | 17 (74%) |
Primary vs. secondary prophylaxis, n (%) | 8 (35%) vs. 15 (65%) |
BMI body mass index; S-ICD subcutaneous implanted cardioverter/defibrillator; LVEF left ventricular ejection fraction